Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Immunopharmacol Immunotoxicol ; 32(3): 422-5, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20095801

RESUMO

BACKGROUND: Alopecia areata (AA) development is attributed to a T cell involved autoimmune process. Apoptosis is one of the suspected culprits in pathogenesis of this disorder. This disorder can be treated by contact sensitizers like diphencyprone (DPCP). We investigated the effects of treatment with DPCP on the expression of Bcl-2 protein in hair follicle epithelial cells of AA patients and its relation to clinical response to treatment. MATERIALS AND METHODS: Patients with chronic and extensive AA who had not received any treatment for at least 6 months were included. Furthermore, 3-mm punch biopsies were obtained from the affected areas before starting the treatment, and, six months after DPCP application, punch biopsies of the same size were taken from the following groups of patients: Group 1: six patients with complete hair regrowth, Group 2: six patients with partial regrowth, and Group 3: six patients with no regrowth. The samples were studied by immunohistochemistry to detect and compare the rate of Bcl-2 expression. RESULTS: Level of Bcl-2 expression in respondent patients (Group 1) was significantly higher after DPCP treatment (36.50 +/- 4.23) compared to pretreatment state (3.67 +/- 1.406, P < 0.001). Similar finding was observed in second group with partial regrowth (17.67 +/- 1.745 versus 5.33 +/- 2.076, P < 0.01). Such significant change was not observed in third group (4.75 +/- 1.315 versus 3.50 +/- 0.645, P > 0.05). CONCLUSION: The results of this study indicate the positive effect of DPCP on regulation (inhibition) of apoptotic process in patients with AA.


Assuntos
Alopecia em Áreas/tratamento farmacológico , Ciclopropanos/uso terapêutico , Folículo Piloso/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Apoptose/efeitos dos fármacos , Feminino , Humanos , Masculino , Proteínas Proto-Oncogênicas c-bcl-2/análise , Resultado do Tratamento
2.
BMC Dermatol ; 5: 11, 2005 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-16259629

RESUMO

BACKGROUND: The study aimed at evaluating the prevalence of thyroid function abnormalities in patients with alopecia areata (AA) and its association with other autoimmune diseases and various autoimmune antibodies. METHOD: We retrospectively analyzed medical records of 123 patients with AA. The main site of involvement, pattern, and extent of alopecia as well as presence of the similar disease in first-degree family members and serologic status of patients were recorded. RESULTS: Participating in the study were 57 males and 66 females (6 to 59 years old). In the majority of patients (69.9%) the disease was manifested in the first two decades of life. Patients with family members having alopecia were recorded in 24.4%. Thyroid function abnormalities were found in 8.9% of patients. Positive autoimmune antibodies were associated with AA in 51.4% of patients with no significant association between the severity and duration of disease and presence of these antibodies. CONCLUSION: The incidence of positive auto-immune antibodies in Iranian patients is higher than previous reports. Concerning the female:male ratio, thyroid function tests and the prevalence of alopecia in first-degree relatives, our results are compatible with previous data obtained from different ethnic populations. Previous reports documented that a greater severity and longer duration of AA were seen in the early onset forms; however our result are relatively different which could be explained by differences in genetic factors.


Assuntos
Alopecia em Áreas/imunologia , Autoanticorpos/sangue , Doenças da Glândula Tireoide/complicações , Glândula Tireoide/imunologia , Adolescente , Adulto , Distribuição por Idade , Alopecia em Áreas/complicações , Alopecia em Áreas/genética , Doenças Autoimunes/epidemiologia , Criança , Família , Feminino , Humanos , Irã (Geográfico) , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Testes de Função Tireóidea
3.
Int J Dermatol ; 44(6): 470-6, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15941433

RESUMO

BACKGROUND: Pemphigus is a rare and chronic life-threatening disease. The clinical picture varies in reports from different regions of the world. OBJECTIVE: To define the clinical forms of pemphigus in a large cohort of patients. METHODS: Prospective analysis of 1209 patients diagnosed and followed at the Pemphigus Research Unit, Tehran University for Medical Sciences, from 1984 to 2003. RESULTS: The mean age at onset was 42 years with a female to male ratio of 1.5/1. The most frequent form was pemphigus vulgaris. In pemphigus vulgaris, patients' mucous membrane involvement alone was observed in 18%, skin involvement alone in 12%, and both in 70%. Pemphigus foliaceus was observed in 7% of the patients. Most complications were iatrogenic. CONCLUSION: In Iran, pemphigus vulgaris is the most frequent form of pemphigus. Females are more prone to the disease. The incidence of pemphigus in Tehran is approximately 1.6 per 100,000/year, and in Iran 1.0 per 100,000/year. The age of onset was lower than classically reported. Death occurred in 6.2% of the patients. In pemphigus vulgaris, the mucosal and skin form together had a worse prognosis than the other clinical forms.


Assuntos
Pênfigo/epidemiologia , Adolescente , Corticosteroides/uso terapêutico , Adulto , Idade de Início , Idoso , Idoso de 80 Anos ou mais , Azatioprina/uso terapêutico , Pré-Escolar , Feminino , Imunofluorescência , Humanos , Imunossupressores/uso terapêutico , Irã (Geográfico)/epidemiologia , Masculino , Pessoa de Meia-Idade , Pênfigo/complicações , Pênfigo/diagnóstico , Pênfigo/tratamento farmacológico , Estudos Prospectivos , Distribuição por Sexo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...